BRB
Biological Regenerative Blood 

Biological Regenerative Blood (BRB) technologies utilize cells and their products, as well as tissues, in treatment.  They positively affect ovarian and testicular function, cell and embryo quality, and endometrial receptivity for embryo implantation, thereby overall enhancing reproductive success.

 

• hcPRP (Autologous Activated highly concentrated Platelet-Rich Plasma): The increased platelet concentration in hcPRP leads to a higher concentration of growth factors released from activated platelets, thus significantly enhancing their effect.

​

• BRF (Autologous Activated Bioregenerative Fibrin): BRF serves as a biodegradable component with multifunctional roles, providing an ideal substrate for tissues, cells, and/or their products while playing a crucial role in achieving hemostasis

 

• Stem Cells (SC): Stem cells have local positive effects on existing stem and other diverse cells, which manifest differently depending on the needs of the target tissue or organ.

 

AMSC: Stem cells (predominantly hematopoietic) from peripheral blood after bone marrow mobilization are collected via aphaeresis, a procedure involving the collection of blood from the venous system and the isolation of stem cells.

 

BMSC: Collected by aspiration of the bone marrow  (predominantly mesenchymal), which involves drilling into the bone and directly sampling from the marrow.

 

• THERAPEUTIC PLASMA EXCHANGE (TPE) refreshes the patient's plasma removing the particles that are contributors to disease and accelerated ageing. TPE is a medical procedure that involves removing, treating, and returning blood plasma to the body.

​

​

​